Acute HIV infection – Diagnostics – Overview of Information and Clinical Research

Acute HIV infection is the earliest stage of infection with the human immunodeficiency virus, a critical window that typically develops within two to four weeks after the virus enters the body. During this time, the virus multiplies rapidly, the immune system begins its fight, and many people experience flu-like symptoms that are often mistaken for other common illnesses.

Introduction: Who Should Undergo Diagnostics

Getting tested for acute HIV infection is important for anyone who might have been recently exposed to the virus or who develops certain symptoms that could signal infection. Because acute HIV infection often causes symptoms that look like the flu, mononucleosis, or other common viral illnesses, it can be easy to miss. This is why knowing when to seek diagnostic testing can make a life-changing difference.

You should consider getting tested for acute HIV if you have recently had sex without a condom, especially with someone whose HIV status you do not know. Sharing needles or syringes for drug use is another situation where testing is advisable. If you believe you may have been exposed to HIV through contact with infected blood or other body fluids, seeking diagnostics quickly is essential. Additionally, if you develop symptoms such as fever, headache, rash, swollen lymph nodes, or sore throat within weeks of a possible exposure, it is wise to discuss HIV testing with a healthcare provider right away.^[1]^[2]

Healthcare professionals should have a high level of suspicion for acute HIV infection in anyone presenting with flu-like symptoms or signs of a viral syndrome, particularly when the person has known risk factors. Because the early phase of infection is when HIV is most easily transmitted to others due to extremely high levels of the virus in the blood, early diagnosis helps protect both the individual and their partners. Testing is recommended for all people aged 13 to 64 at least once in their lifetime, and more frequently for those at higher risk.^[5]

⚠️ Important

Not everyone with acute HIV infection will have symptoms. Some people experience no symptoms at all during this earliest stage. This is why testing is so important, especially after a known exposure. The only reliable way to know if you have HIV is to get tested, regardless of whether you feel sick or not.^[3]

Diagnostic Methods for Identifying Acute HIV Infection

Diagnosing acute HIV infection can be challenging because it occurs during a very specific window of time when standard antibody tests may not yet detect the virus. During acute infection, the virus is multiplying rapidly throughout the body, but the immune system has not yet produced enough antibodies (proteins made by your immune system to fight infection) to show up on most tests. This period is sometimes called the window period.^[3]^[8]

Understanding Different HIV Tests

There are several types of tests used to detect HIV, and they differ in what they look for and how soon after infection they can provide accurate results. The most commonly used tests look for HIV antibodies, but these take time to develop—sometimes several weeks or even months. This is why antibody-only tests are not the best choice when acute HIV infection is suspected.^[15]

The gold standard for diagnosing acute HIV infection is testing for the virus itself, rather than waiting for the body’s response to it. This is done through a test that measures HIV RNA in the blood. RNA is the genetic material of the virus, and during acute infection, there are very high levels of HIV RNA circulating in the bloodstream. This test is sometimes called a viral load test, and it can detect HIV as early as 10 to 14 days after infection, making it the most sensitive test for catching the infection early.^[4]^[6]

Another highly effective approach is the use of antigen/antibody combination tests, also known as fourth-generation tests. These tests look for both HIV antibodies and a part of the virus itself called p24 antigen. The p24 antigen appears in the blood shortly after infection, usually before antibodies develop. This type of test can detect HIV infection within two to six weeks after exposure, making it more reliable than older antibody-only tests during the early stages of infection. Laboratory-based antigen/antibody tests, which require blood to be drawn from a vein, are generally more accurate than rapid tests during acute infection.^[8]^[14]

When Standard Tests May Not Be Enough

If you go to a clinic or doctor’s office with symptoms that could be acute HIV infection, but a standard antibody test comes back negative or indeterminate, your healthcare provider should consider ordering an HIV RNA test. This is especially important if you have recently been exposed to HIV or if your symptoms strongly suggest acute infection. A negative antibody test during this window period does not mean you are HIV-negative; it may simply mean that your body has not yet produced enough antibodies to be detected.^[6]^[10]

Point-of-care rapid tests, including self-tests done at home, are convenient and provide results quickly—often within 30 minutes. However, these tests typically only detect antibodies and may miss acute HIV infection entirely. If you use a rapid or home test after a possible exposure and the result is negative, it is important to follow up with a laboratory-based test or an HIV RNA test to be certain.^[8]

Confirming the Diagnosis

When HIV RNA is detected at high levels in the blood and antibody tests are negative or indeterminate, a diagnosis of acute HIV infection can be presumed. Current guidelines suggest that if the HIV RNA level is very high—typically above several thousand copies per milliliter—it strongly indicates acute infection. However, because laboratory errors can happen, it is important to confirm the diagnosis with repeat testing within a few weeks. During this follow-up, both HIV RNA and antibody tests should be repeated to document seroconversion, which is the process of the body developing detectable antibodies to HIV.^[10]^[12]

Once HIV infection is confirmed, additional baseline tests are performed to assess the health of the immune system. This includes measuring the number of CD4 T cells, a type of white blood cell that HIV attacks. A CD4 count helps doctors understand how much damage the virus has done to the immune system. The viral load test is also repeated to track the amount of virus in the blood over time. These tests together help guide decisions about treatment and monitoring.^[15]

Other Important Tests

After diagnosing acute HIV infection, healthcare providers will typically screen for other infections that can be transmitted in similar ways. This includes testing for sexually transmitted infections such as syphilis, gonorrhea, and chlamydia, as well as hepatitis B and hepatitis C. Tuberculosis screening is also recommended. These tests help ensure comprehensive care and identify any other conditions that need treatment.^[10]

A test called an HIV genotype may also be performed. This test analyzes the genetic makeup of the virus to check for any mutations that could make it resistant to certain HIV medications. Knowing this information upfront helps doctors choose the most effective treatment regimen from the start.^[10]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or strategies for managing HIV. People with acute HIV infection are sometimes invited to participate in clinical trials because this early stage of infection offers unique opportunities for research, particularly in understanding how to preserve immune function and reduce the size of the viral reservoir in the body.^[6]

To qualify for a clinical trial focused on acute HIV infection, participants typically need to meet specific diagnostic criteria. The most common requirement is confirmation of acute HIV infection through laboratory testing. This usually means having a positive HIV RNA test with a high viral load, combined with a negative or indeterminate HIV antibody test. Some trials may require documentation of the approximate timing of infection based on symptoms or known exposure.^[4]

Baseline measurements are critical for clinical trial enrollment. These include CD4 T cell counts to assess the state of the immune system, HIV viral load measurements to determine the amount of virus in the blood, and HIV genotype testing to check for drug resistance. Trials may also require additional blood tests to evaluate overall health, kidney and liver function, and the presence of other infections. These tests ensure that participants are suitable for the study and help researchers measure the effects of the treatment being tested.^[10]

Some clinical trials may have specific timing requirements. For example, a trial might only accept participants who have been infected for fewer than four weeks or who have not yet started antiretroviral therapy. Documentation of the acute infection stage, including the timing of symptom onset or known exposure, is often needed. Healthcare providers can help determine whether a person with newly diagnosed acute HIV infection might be a candidate for a clinical trial and provide referrals to research centers conducting such studies.^[6]

Prognosis and Survival Rate

Prognosis

The prognosis for people diagnosed with acute HIV infection has improved dramatically over the past few decades. While there is no cure for HIV, modern antiretroviral therapy can control the virus effectively and allow people to live long, healthy lives. Research shows that individuals who start treatment early—during the acute or early stages of infection—can have life expectancies similar to those of people without HIV.^[1]^[5]

Starting treatment during acute infection offers several important benefits. It helps preserve immune system function by preventing the virus from destroying too many CD4 T cells. Early treatment also reduces the time it takes to achieve an undetectable viral load, meaning the amount of virus in the blood becomes so low that it cannot be detected by standard tests. When someone maintains an undetectable viral load for at least six months, they cannot transmit HIV to others through sex—a concept known as “undetectable equals untransmittable” or U=U.^[6]^[12]

Without treatment, HIV infection progresses through stages over the course of months and years. Acute HIV infection is followed by chronic HIV infection, during which the virus continues to damage the immune system gradually. Eventually, without treatment, HIV can progress to AIDS, the most advanced stage of infection. At this point, the immune system is severely weakened, making the body vulnerable to serious infections and certain cancers. However, with consistent treatment, most people never progress to AIDS.^[1]^[5]

Factors that can affect prognosis include how quickly treatment is started after infection, how well a person adheres to their medication regimen, the presence of drug-resistant virus, and overall health status. Early diagnosis and immediate linkage to care are crucial. People who remain engaged in care, take their medications consistently, and attend regular medical appointments have the best outcomes. Access to healthcare, social support, and addressing factors like mental health and substance use also play important roles in long-term health.^[10]^[12]

Survival Rate

With effective antiretroviral therapy, people diagnosed with HIV during the acute stage can expect to live as long as people who do not have the virus. This represents a remarkable advancement in HIV treatment. Decades ago, an HIV diagnosis carried a very poor prognosis, but today’s medicines have transformed HIV into a manageable chronic condition.^[1]

The key to achieving excellent survival rates is early diagnosis and consistent treatment. Studies show that individuals who begin treatment soon after infection and maintain an undetectable viral load have greatly reduced risks of illness and death from HIV-related causes. They also have lower risks of developing opportunistic infections and other complications that were once common in people living with HIV.^[6]

It is important to note that survival outcomes can vary based on individual circumstances and access to care. People who start treatment late, after the immune system has already been significantly damaged, may face more health challenges. However, even in these cases, treatment can still improve health and extend life considerably. The global effort to diagnose HIV early, link people to care quickly, and ensure they have access to effective medications continues to improve survival rates worldwide.^[5]

#1 Clinical Trials Search in Europe